July 09, 2020 Steve Sandweg
Mr. Sandweg has close to 30 years of sales, sales training, and sales management experience. Over the past 22 years, he has held roles of increasing responsibility within the cardiovascular and structural heart space for Boston Scientific, Medtronic, and Direct Flow Medical. While with Medtronic, he helped to launch several strategic products to include, Endeavor and Resolute, the companies first drug eluting stents. He also served on the original US Sales Management Team responsible for launching CoreValve and CoreValve EVOLUT, the companies first transcatheter aortic valve devices. Prior to joining Keystone Heart, Mr. Sandweg served as the Director of US Market Development for Direct Flow Medical where he was responsible for all field operations supporting the SALUS TAVR Trial.